Ana Carolina de Souza Peratelli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ana Carolina de Souza Peratelli has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Danielle Satie Kassada
Professora Doutora da Área de Saúde Pública e Coletiva. Faculdade de Enfermagem da Universidade Estadual de Campinas – UNICAMP. Campinas/SP, Brasil
2 shared publications - Guilherme Coelho
Faculdade de Ciências Médicas, Universidade Estadual de Campinas (Unicamp), Campinas, SP, Brasil
2 shared publications - Igor de Lima Peixoto Rocha
School of Nursing, University of Campinas, Campinas 13083-887, Brazil
2 shared publications - Larissa Marques Suardi
School of Nursing, University of Campinas, Campinas 13083-887, Brazil
1 shared publication
Latest Publications
- Open Access
Social Vulnerability and Its Effects on PM2.5 Related Circulatory and Respiratory Mortality in Campinas, São Paulo, Brazil
Ambient air pollution is a major environmental health risk, with impacts that may be unevenly distributed across vulnerable populations, particularly in urban areas under changing climate conditions. This study assessed whether social conditions modify the association between exposure to fine particulate matter (PM2.5) and deaths from circulatory and respiratory diseases in Campinas, Brazil. An ecological time-series study was conducted from 2010 to 2023 using monthly death data aggregated at the catchment-area level of 63 Primary Health Care Centers, stratified into four vulnerability groups. Associations between monthly PM2.5 concentrations and mortality rates were estimated using distributed lag non-linear models within a generalized additive modeling framework, adjusting for meteorological variables, ozone, seasonality, and long-term trends. A total of 38,311 cardiorespiratory deaths were recorded. Mortality rates varied non-linearly across strata, and a statistically significant positive association between PM2.5 exposure and mortality was observed only in the intermediate–high vulnerability group at higher pollution levels. No significant associations were identified in the lowest or highest vulnerability strata. These findings indicate that social context modifies air pollution–related mortality risks, highlighting the importance of incorporating vulnerability dimensions into air quality assessments and climate-related public health strategies.
Open AccessSocial Vulnerability and Its Effects on PM2.5 Related Circulatory and Respiratory Mortality in Campinas, São Paulo, Brazil
Ambient air pollution is a major environmental health risk, with impacts that may be unevenly distributed across vulnerable populations, particularly in urban areas under changing climate conditions. This study assessed whether social conditions modify the association between exposure to fine particulate matter (PM2.5) and deaths from circulatory and respiratory diseases in Campinas, Brazil. An ecological time-series study was conducted from 2010 to 2023 using monthly death data aggregated at the catchment-area level of 63 Primary Health Care Centers, stratified into four vulnerability groups. Associations between monthly PM2.5 concentrations and mortality rates were estimated using distributed lag non-linear models within a generalized additive modeling framework, adjusting for meteorological variables, ozone, seasonality, and long-term trends. A total of 38,311 cardiorespiratory deaths were recorded. Mortality rates varied non-linearly across strata, and a statistically significant positive association between PM2.5 exposure and mortality was observed only in the intermediate–high vulnerability group at higher pollution levels. No significant associations were identified in the lowest or highest vulnerability strata. These findings indicate that social context modifies air pollution–related mortality risks, highlighting the importance of incorporating vulnerability dimensions into air quality assessments and climate-related public health strategies.
- Open Access
Factors Associated with the Clinical Outcome of Severe Acute Respiratory Syndrome Due to COVID-19 in Brazil, 2024
Severe acute respiratory syndrome (SARS), caused by the COVID-19 virus, continues to pose a significant public health challenge in Brazil, particularly in 2024, with high mortality rates among vulnerable groups. This study aimed to describe the sociodemographic, clinical and vaccination profiles of SARS cases due to COVID-19 in Brazil in 2024, as well as analysing factors associated with clinical outcomes such as death, admission to the intensive care unit (ICU) and the need for ventilatory support. A total of 30,529 reported cases were analysed. On average, the interval between the last vaccine dose and symptom onset was 30.31 months (SD = 6.77), while the interval between symptom onset and clinical outcome was 13.26 days (SD = 16.55), revealing significant variability. The results showed higher mortality rates among men (23.7%) than women (19.1%) (p < 0.0001). Mortality increased progressively with age, reaching 24.4% in individuals aged 60 years or older, whereas rates were below 2% in children under 10 years of age. The highest proportions of deaths were observed regionally in the Northeast (26.8%) and North (22.6%), in contrast to the Midwest (17.7%) (p < 0.0001). Men were also more likely to require ICU admission (38.1% vs. 33.6%) and ventilation (62.9% vs. 60.5%). A time interval of over 24 months since the last vaccine dose was associated with higher mortality (21.9% vs. 20.6%; p = 0.0005). These results highlight the importance of ongoing surveillance and updating the vaccination schedule, particularly for more vulnerable populations.
Open AccessFactors Associated with the Clinical Outcome of Severe Acute Respiratory Syndrome Due to COVID-19 in Brazil, 2024
Severe acute respiratory syndrome (SARS), caused by the COVID-19 virus, continues to pose a significant public health challenge in Brazil, particularly in 2024, with high mortality rates among vulnerable groups. This study aimed to describe the sociodemographic, clinical and vaccination profiles of SARS cases due to COVID-19 in Brazil in 2024, as well as analysing factors associated with clinical outcomes such as death, admission to the intensive care unit (ICU) and the need for ventilatory support. A total of 30,529 reported cases were analysed. On average, the interval between the last vaccine dose and symptom onset was 30.31 months (SD = 6.77), while the interval between symptom onset and clinical outcome was 13.26 days (SD = 16.55), revealing significant variability. The results showed higher mortality rates among men (23.7%) than women (19.1%) (p < 0.0001). Mortality increased progressively with age, reaching 24.4% in individuals aged 60 years or older, whereas rates were below 2% in children under 10 years of age. The highest proportions of deaths were observed regionally in the Northeast (26.8%) and North (22.6%), in contrast to the Midwest (17.7%) (p < 0.0001). Men were also more likely to require ICU admission (38.1% vs. 33.6%) and ventilation (62.9% vs. 60.5%). A time interval of over 24 months since the last vaccine dose was associated with higher mortality (21.9% vs. 20.6%; p = 0.0005). These results highlight the importance of ongoing surveillance and updating the vaccination schedule, particularly for more vulnerable populations.